The Modernisation of Healthcare will be one of the Greatest Growth Drivers of the 21st Century NCL is a specialist healthcare investor. We create value by identifying companies who are at the forefront of transformational change. By applying the capital and human skills required to navigate this rapidly evolving sector, we prepare our companies to succeed both clinically and commercially. Our focus is on the pioneers. Companies that are actively using innovation and technological advancement to help prevent, treat and cure a wide range of conditions. Our mission is to address the challenges of our future health needs, whilst creating the next generation of valuable businesses.
Location: United Kingdom, England, London
Employees: 11-50
Founded date: 2010
Investment Type: Venture Capital
Portfolio 9
| Date | Name | Website | Total Raised | Location |
| - | Revolo Bio... | revolobio.com | $126.36M | United Sta... |
| - | Sana | sana.io | - | Belize, Co... |
| - | Centauri T... | centauritherapeutics.com | $36.93M | United Kin... |
| - | Azadyne | azadyne.com | - | - |
| - | Every woma... | viramal.com | - | United Kin... |
| - | TC BioPhar... | tcbiopharm.com | - | United Kin... |
| - | Ampersand ... | ampersandhealth.co.uk | - | - |
| - | Emteq | emteq.net | - | United Kin... |
| - | Curesponse | curesponse.com | $14M | - |
News 24
| Date | Title | Description |
| 21.10.2020 | Research by emteq labs reveals how emotion measurement could redefine treatment for anxiety, depression and PTSD | The AI Journal has covered the latest research by portfolio Emteq, acknowledging their current success milestones and the implications of their research for emotion measurement for the future. “New research from the emotion-sensing wearabl... |
| 23.09.2020 | LifeArc and UK government’s Future Fund provide £3.0m in funding to Centauri Subsidiary Avvinity Therapeutics | LifeArc, an independent medical research charity,announces a £3.0m co-investment in British biotech Avvinity Therapeutics alongside the UK government’s Future Fund. Lead investor LifeArc leveraged £1.5m of seed funding provided to Avvinity ... |
| 22.09.2020 | Immune Regulation Limited raises £40.6 million / $53.4 million Series B Equity Financing | Series B round led by Morningside Ventures provides foundation to accelerate the drug development of first-in-class immune-resetting therapies (London UK and Boston USA, 21 September 2020) Immune Regulation Limited (“Immune Regulation”), a... |
| 17.09.2020 | Immune system ‘bully boys’ square up to coronavirus crisis | Scalable, affordable, effective. Read about TC Biopharm’s stunning progress in the Financial Times here. “After winning approval from the UK’s Medicines and Healthcare Products Regulatory Agency to treat Covid-19 patients, the privately he... |
| 01.07.2020 | TC BioPharm C-19 Therapy Trials Approved | Porfolio company TC BioPharm has had their T-cell therapy approved for trials in Scotland for Covid-19 that would boost patients’ immune systems before their need for intensive care. TC BioPharm has developed a method for cultivating lar... |
| 11.06.2020 | NCL is UK Lead of $6M Series A for Curesponse | NCL is delighted to welcome Curesponse to our portfolio, a breakthrough cancer precision medicine company. Their platform, cResponse, accurately and quickly predicts a patient’s response to cancer treatment. The company’s platform, cRespon... |
| 06.04.2020 | TC BioPharm to begin trialling T-cell therapy against Covid-19 | Fantastic to see the Telegraph and the Daily Mail covering the work of TC BioPharm, one of our portfolio companies. Talks with government are taking place to begin trialing their T-cell cancer therapy against Covid-19. Happy our companies a... |
| 17.09.2019 | Award for ALERT at product launch! | After an absolutely fantastic product launch last week, the team at Alert Technology are slowly coming back down to earth following this year’s Contamination Expo at the NEC, Birmingham. We had an overwhelming response at the Expo from b... |
| 13.08.2019 | The child who inspired Andiamo – London’s most exciting tech firm | The agony suffered by tragic Diamo Parvez motivated parents Samiya and Naveed to alleviate the suffering of others through the use of an array of cutting-edge technology Jonathan Symcox 9:00am 5th Aug 2019. Andiamo is using Big Data, AI... |
| 09.05.2019 | These face-reading glasses track physical and mental health | Surgeon Charles Nduka has developed sensor tech to track facial expressions and is currently using it with patients with Parkinson’s. His next target: depression Charles Nduka is a plastic surgeon who mends the bodies of his patients with ... |
Show more